Cargando…

Hydrogels: 3D Drug Delivery Systems for Nanoparticles and Extracellular Vesicles

Synthetic and naturally occurring nano-sized particles present versatile vehicles for the delivery of therapy in a range of clinical settings. Their small size and modifiable physicochemical properties support refinement of targeting capabilities, immune response, and therapeutic cargo, but rapid cl...

Descripción completa

Detalles Bibliográficos
Autores principales: Chabria, Yashna, Duffy, Garry P., Lowery, Aoife J, Dwyer, Róisín M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8615452/
https://www.ncbi.nlm.nih.gov/pubmed/34829923
http://dx.doi.org/10.3390/biomedicines9111694
_version_ 1784604108280299520
author Chabria, Yashna
Duffy, Garry P.
Lowery, Aoife J
Dwyer, Róisín M.
author_facet Chabria, Yashna
Duffy, Garry P.
Lowery, Aoife J
Dwyer, Róisín M.
author_sort Chabria, Yashna
collection PubMed
description Synthetic and naturally occurring nano-sized particles present versatile vehicles for the delivery of therapy in a range of clinical settings. Their small size and modifiable physicochemical properties support refinement of targeting capabilities, immune response, and therapeutic cargo, but rapid clearance from the body and limited efficacy remain a major challenge. This highlights the need for a local sustained delivery system for nanoparticles (NPs) and extracellular vesicles (EVs) at the target site that will ensure prolonged exposure, maximum efficacy and dose, and minimal toxicity. Biocompatible hydrogels loaded with therapeutic NPs/EVs hold immense promise as cell-free sustained and targeted delivery systems in a range of disease settings. These bioscaffolds ensure retention of the nano-sized particles at the target site and can also act as controlled release systems for therapeutics over a prolonged period of time. The encapsulation of stimuli sensitive components into hydrogels supports the release of the content on-demand. In this review, we highlight the prospect of the sustained and prolonged delivery of these nano-sized therapeutic entities from hydrogels for broad applications spanning tissue regeneration and cancer treatment. Further understanding of the parameters controlling the release rate of these particles and efficient transfer of cargo to target cells will be fundamental to success.
format Online
Article
Text
id pubmed-8615452
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-86154522021-11-26 Hydrogels: 3D Drug Delivery Systems for Nanoparticles and Extracellular Vesicles Chabria, Yashna Duffy, Garry P. Lowery, Aoife J Dwyer, Róisín M. Biomedicines Review Synthetic and naturally occurring nano-sized particles present versatile vehicles for the delivery of therapy in a range of clinical settings. Their small size and modifiable physicochemical properties support refinement of targeting capabilities, immune response, and therapeutic cargo, but rapid clearance from the body and limited efficacy remain a major challenge. This highlights the need for a local sustained delivery system for nanoparticles (NPs) and extracellular vesicles (EVs) at the target site that will ensure prolonged exposure, maximum efficacy and dose, and minimal toxicity. Biocompatible hydrogels loaded with therapeutic NPs/EVs hold immense promise as cell-free sustained and targeted delivery systems in a range of disease settings. These bioscaffolds ensure retention of the nano-sized particles at the target site and can also act as controlled release systems for therapeutics over a prolonged period of time. The encapsulation of stimuli sensitive components into hydrogels supports the release of the content on-demand. In this review, we highlight the prospect of the sustained and prolonged delivery of these nano-sized therapeutic entities from hydrogels for broad applications spanning tissue regeneration and cancer treatment. Further understanding of the parameters controlling the release rate of these particles and efficient transfer of cargo to target cells will be fundamental to success. MDPI 2021-11-15 /pmc/articles/PMC8615452/ /pubmed/34829923 http://dx.doi.org/10.3390/biomedicines9111694 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Chabria, Yashna
Duffy, Garry P.
Lowery, Aoife J
Dwyer, Róisín M.
Hydrogels: 3D Drug Delivery Systems for Nanoparticles and Extracellular Vesicles
title Hydrogels: 3D Drug Delivery Systems for Nanoparticles and Extracellular Vesicles
title_full Hydrogels: 3D Drug Delivery Systems for Nanoparticles and Extracellular Vesicles
title_fullStr Hydrogels: 3D Drug Delivery Systems for Nanoparticles and Extracellular Vesicles
title_full_unstemmed Hydrogels: 3D Drug Delivery Systems for Nanoparticles and Extracellular Vesicles
title_short Hydrogels: 3D Drug Delivery Systems for Nanoparticles and Extracellular Vesicles
title_sort hydrogels: 3d drug delivery systems for nanoparticles and extracellular vesicles
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8615452/
https://www.ncbi.nlm.nih.gov/pubmed/34829923
http://dx.doi.org/10.3390/biomedicines9111694
work_keys_str_mv AT chabriayashna hydrogels3ddrugdeliverysystemsfornanoparticlesandextracellularvesicles
AT duffygarryp hydrogels3ddrugdeliverysystemsfornanoparticlesandextracellularvesicles
AT loweryaoifej hydrogels3ddrugdeliverysystemsfornanoparticlesandextracellularvesicles
AT dwyerroisinm hydrogels3ddrugdeliverysystemsfornanoparticlesandextracellularvesicles